Description
SARS-CoV-2 virus stock is produced by cell culture and formulated with purified, intact viral particles. The virus particles have been inactivated to render them non-infectious and refrigerator stable. The inactivation was verified in a standard microbiological growth protocol. SARS-CoV-2 stock can be used in the development of SARS-CoV-2 diagnostics and in vaccine development and R&D.